Loading...
NPI 1821727371 · Bolingbrook, IL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
A&a Medlabs LLC is a clinical medical laboratory provider located in Bolingbrook, Illinois. This profile covers 1 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | A&a Medlabs LLC |
| Address | 498 W Boughton Rd |
| City | Bolingbrook |
| State | IL |
| ZIP | 60440 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 9, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $6.3M |
| Medicaid | $2.7K |
A&A MEDLABS LLC’s billing profile is overwhelmingly driven by a single service line: K1034, the provision of COVID-19 nonprescription self‑administered and self‑collected tests. The provider reported 523K Medicare claims for K1034 with $12 avg paid/claim generating $6.3M in Medicare revenue, and 909 Medicaid claims for K1034 with $3 avg paid/claim generating $2.7K in Medicaid revenue. This pattern indicates the operation centers on distribution or mass provisioning of over‑the‑counter COVID test kits rather than a diversified clinical laboratory mix.
Revenue concentration is extreme across both payers: the precomputed top‑3 Medicare codes account for 100.0% of the provider’s Medicare revenue and the top‑3 Medicaid codes account for 100.0% of its Medicaid revenue. Because all reported payer revenue collapses to that very small set of codes (in practice a single code K1034), A&A MEDLABS has highly concentrated earnings tied to a single product/service. This concentration suggests material business risk if demand or coverage for that code changes.
The payer mix is effectively Medicare-dominated: lifetime Medicare revenue is $6.3M versus lifetime Medicaid revenue of $2.7K. In scale, Medicaid activity is negligible relative to Medicare, so the provider functions operationally as a single‑payer dependent entity with most commercial and Medicaid exposure minimal or absent in the dataset.
On Medicare competitive standing the provider is an outlier: its Medicare K1034 activity ranks #78 of 30143 providers nationally and is characterized as 100th percentile, an “extreme outlier” far above typical national volume for this code. That rank positions A&A MEDLABS as a major national participant for K1034 specifically, indicating disproportionate market reach or distribution capacity for over‑the‑counter COVID tests compared with nearly all peers.
By contrast, the provider’s Medicaid standing for the same code is modest: K1034 ranks #25 of 59 providers in‑state at the 59th percentile and is described as typical or unremarkable. This suggests that while A&A MEDLABS is an unusually large Medicare reporter for K1034, its Medicaid footprint in Illinois is comparatively ordinary and not a market leadership position.
The reimbursement profile shows the business generates revenue primarily through very high claim volume rather than high per-claim payments: Medicare avg paid/claim for K1034 is $12 while Medicaid avg paid/claim is $3. Given the large Medicare claim count (523K) versus per-claim rates, the operation appears oriented toward mass distribution of low‑unit‑price test kits rather than high‑complexity laboratory procedures.
A&A MEDLABS’ NPI was enumerated on 2022-06-09 (~4 years ago), indicating a relatively recent entry date for the provider. Despite the short tenure, the firm has scaled to substantial Medicare volume for K1034, implying rapid growth in this narrow service line since enumeration and potential reliance on continued coverage and demand for that specific code.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 523,010 | $10 | $6.3M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 25 | 1,150 | 720 | $10 | $414.9K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 910 | $1 | $2.7K |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 25 | 60 | 660 | $1 | $3.2K |
Other providers in the same ZIP code as A&a Medlabs LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Village Of Bolingbrook Illinois | IL | Land Ambulance | $429.5K | $14.1M |
| Vna Health Care | IL | Federally Qualified Health Center (FQHC) | $0 | $14M |
| Apria Healthcare LLC | IL | Durable Medical Equipment & Medical Supplies | $0 | $7M |
| Ghiath Al Kassar | IL | Pediatrics Physician | $0 | $6.4M |
| Manju Akhand | IL | Pediatrics Physician | $0 | $3.2M |
| Moazzam Saeed | IL | Pediatrics Physician | $0 | $3.2M |
| Milad Nourahmadi | IL | General Practice Dentistry | $0 | $3M |
| Apex Clinical Laboratories LLC | IL | Clinical Medical Laboratory | $1.6M | $155.1K |
| Irma Ahmed | IL | Retina Specialist (Ophthalmology) Physician | $152.7K | $763.9K |
| Mushtaq Mohammed | IL | Hospitalist Physician | $478.2K | $409K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.